Allogene Therapeutics, Inc. Common Stock (NASDAQ: ALLO) last traded at $2.09, down 0.48% on the session. The quote above updates while this page is open; the figures below are drawn from Allogene Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Allogene Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ALLO. Its market capitalisation is $722.08 million.
Valuation measures for Allogene Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $722.08M |
|---|---|
| Enterprise value | $797.37M |
| Price / book | 1.66 |
| Beta | 2.17 |
Trailing-twelve-month figures tagged in Allogene Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$165.49M |
| Return on equity | -37.94% |
| Cash | $38.63M |
Range and volume for ALLO over the past 52 weeks.
| 52-week high | $4.46 |
|---|---|
| 52-week low | $1.04 |
| Volume | 4.33M |
| Average volume | 7.85M |
| Previous close | $2.10 |
Dividend history for Allogene Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.